Starting tirzepatide: what the 2.5mg starter dose is really for

Why every tirzepatide journey begins at 2.5mg, not higher

Tirzepatide activates two gut-hormone receptors simultaneously: GLP-1 and GIP. That dual action is part of what makes it effective, but it also means the medicine has a pronounced effect on gastric emptying from the very first injection. Starting at 2.5mg keeps that effect modest while your digestive system adapts. Think of it as the calibration phase rather than the treatment phase.

This is a point worth sitting with if you arrive at 2.5mg feeling impatient. The dose is not a holding pen; it is doing real, necessary physiological work. Clinical trial participants in the SURMOUNT-1 study (one of the largest trials of any weight-loss medicine, involving over 2,500 adults) followed exactly this graduated approach, and the results at the higher maintenance doses were only possible because tolerability was managed carefully from week one. The trial evidence is published in full by the New England Journal of Medicine for anyone who wants the detail.

Some people wonder whether their starting weight justifies a higher opening dose. It does not. If you want to understand what dosage to start tirzepatide on and why the answer is the same for everyone, that page sets out the clinical reasoning in full, covering BMI, body weight, and prior treatment history. The full tirzepatide dose schedule walks through what comes after that initial period.

What the four-week mark actually means for your next decision

After four weeks at the starter dose of tirzepatide, the decision about whether to increase sits with your prescriber, not with you. They will consider how you've tolerated the medicine, your clinical profile, and the titration schedule outlined in the Summary of Product Characteristics. At nume the prescriber reviews this before every repeat, there are no automatic escalations.

The licensed UK strengths run from 2.5mg up through 5mg, 7.5mg, 10mg, 12.5mg and 15mg. Each step is typically held for at least four weeks. If side effects at any point make increasing uncomfortable, staying at the current dose for longer is an option the prescriber can discuss with you, some patients also ask whether they can begin at 5mg, which is a reasonable question with a clear clinical answer worth reading before your consultation.

One practical note: if your first pen arrives around a bank holiday or you're planning to travel, factor in that the four-week review timing should align with when you can speak to a prescriber. Ordering by Monday midday means next-day delivery, but the review calendar is worth thinking through alongside your diary.

Side effects at the starter dose and how to read them

The most commonly reported side effects at 2.5mg are gastrointestinal: nausea, loose stools, constipation, indigestion, and occasionally burping. These are well-documented in the NHS tirzepatide medicines page, and for most people they are mild, settle within a week or two, and are noticeably less intense at the starter dose than at higher ones.

Knowing this in advance changes how you experience them. If nausea peaks on day two or three and then fades, that is the expected pattern. Eating smaller portions, avoiding very fatty meals, and staying well hydrated all help. If symptoms are severe or persistent (particularly any intense abdominal pain that reaches through to your back) that warrants prompt medical attention, not waiting to see if it passes.

The Mounjaro starter dose page covers the same ground for Mounjaro specifically, since tirzepatide is the active ingredient in both brand contexts. Side effects, tolerability strategies, and the titration sequence are identical; the clinical guidance is the same regardless of which label is on the pen.

What this means before you book a consultation

The starter dose question resolves into a simpler one: are you ready to commit to a graduated, clinically supervised process rather than a fast result? Our guidance on the tirzepatide starting dose explains why the 2.5mg period is short, with most people reaching meaningful doses within two to three months, and why the structure matters throughout. But cutting it short (whether by self-escalating or sourcing medicine without proper clinical oversight) undermines the safety framework the titration schedule is built around.

Tirzepatide is a prescription-only medicine. In the UK, every dose increase requires clinical reassessment, and anyone supplying these medicines without a valid prescription is operating outside the law. If you're considering private treatment, understanding the full cost picture before you start helps you avoid services that skip the clinical steps to offer a lower headline price.

At nume, a prescriber (a real clinician, not a system) reads every consultation the same day it's submitted. If you're ready to begin, start your free consultation and our team will assess whether tirzepatide is the right fit for you.